Hospital Use, Morbidity, and Cancer Risk by Age Group in Neurofibromatosis Type 1: A Nationwide Retrospective Cohort...

Area of Science:

• Genetics and Genomics
• Oncology
• Public Health

Background:

• Neurofibromatosis type 1 (NF1) is a genetic disorder with progressive multi-organ involvement, impacting life expectancy.
• Understanding age-specific complications is crucial for managing NF1 patients effectively.

Purpose of the Study:

• To identify and compare age-specific complications in patients with NF1.
• To analyze the incidence of various neoplasms and comorbidities across different age demographics.

Main Methods:

• A large-scale retrospective study comparing 28,082 NF1 patients with 84,246 matched controls.
• Analysis of hospital use data to determine prominent complications by age group.
• Calculation of rate ratios (RR) for specific malignancies in NF1 patients compared to controls.

Main Results:

• Neoplasms and neurological complications were primary drivers of hospital use across most age groups.
• Significant increases in malignancy rates were observed in specific organs and age brackets, including adrenal gland (0-9 years), female genital organs (10-14 years), and respiratory organs (15-60+ years).
• Other significant malignancy risks included lip, oral cavity, and pharynx (30-39 years), and bone and articular cartilage (40-59 years).

Conclusions:

• Comorbidities and malignancies in NF1 patients exhibit significant age-dependent patterns.
• Physicians require awareness of these age-specific risks for timely diagnosis and management.
• Personalized healthcare strategies are essential for improving outcomes in NF1 patients throughout their lifespan.